Danaher Corporation (DHR) Stock Analysis — Fair Value, Risk & Moat Rating
NYQ · Healthcare · Diagnostics & Research
Is Danaher Corporation a safe investment right now?
Danaher Corporation's Altman Z-Score of 3.87 places it in the safe zone. Our fair value estimate is $190.00 (Watch Zone). Moat rating: 2.6/5 stars.
Could Danaher Corporation go bankrupt? Altman Z-Score analysis
Z-Score of 3.87 is above 3.0, indicating the company is financially healthy by this metric.
- Below 1.8 — Distress Zone (high bankruptcy risk)
- 1.8 to 3.0 — Gray Zone (elevated uncertainty)
- Above 3.0 — Safe Zone (financially healthy)
What drives DHR's Z-Score?
| Component | Formula | Value | Weight | Contribution |
|---|---|---|---|---|
| A · Working Capital / Total Assets | WC / TA | 0.0713 | 1.2 | 0.09 |
| B · Retained Earnings / Total Assets | RE / TA | 0.5618 | 1.4 | 0.79 |
| C · EBIT / Total Assets | EBIT / TA | 0.0539 | 3.3 | 0.18 |
| D · Market Cap / Total Liabilities | MCap / TL | 4.2123 | 0.6 | 2.53 |
| E · Revenue / Total Assets | Rev / TA | 0.2944 | 1.0 | 0.29 |
How has DHR's financial health changed over time?
| Year | Z-Score | Zone |
|---|---|---|
| 2022 | 3.64 | Safe |
| 2023 | 3.77 | Safe |
| 2024 | 4.15 | Safe |
| 2025 | 3.87 | Safe |
Source: Calculated from DHR's latest 10-K filing on SEC EDGAR.
What is Danaher Corporation actually worth?
How we calculated this
| Input | Value | Source |
|---|---|---|
| Predicted EPS (α) | $6.25 | Proprietary blend of reported actuals (1Q actual) + analyst consensus, weighted by α |
| Last Year EPS | $5.05 | Annual report (SEC EDGAR) |
| Analyst Consensus EPS (This Year) | $8.42 | 22 analysts consensus |
| Trailing P/E | 35.7x | Current market pricing |
| Fair P/E (β discount) | 30.4x | Trailing PE adjusted by value discount factor β, hard-capped |
| Earnings Trend (γ) | Accelerating | Directional signal: predicted vs trailing EPS |
Wall Street Reference: Analyst consensus target price is $256.05 (22 analysts). This is shown for reference only and is not used in our valuation model.
Source: Earnings data from SEC EDGAR filings. Market data via Yahoo Finance.
Does Danaher Corporation have a durable competitive advantage?
Moat rating: 2.6/5.
What makes up DHR's moat score?
ROIC Stability
ROIC variability over the past decade. Score: 2/5.
Gross Margin Trend
Gross margin trajectory over the past decade. Score: 3/5.
Switching Costs
Estimated customer lock-in based on margin level. Score: 3/5.
How stable is DHR's return on invested capital?
| Year | ROIC | Trend |
|---|---|---|
| 2022 | 10.8% | — |
| 2023 | 7.4% | Declining |
| 2024 | 7.5% | Stable |
| 2025 | 6.3% | Declining |
Source: ROIC calculated from SEC EDGAR filings.
Is Danaher Corporation's dividend safe?
Can Danaher Corporation afford its dividend?
Payout ratio is 26.4%. FCF covers the dividend 9.0x. 34 consecutive years of payments.
Danaher Corporation's key financial metrics
| Metric | Latest | 1Y Ago | 3Y Ago | Trend |
|---|---|---|---|---|
| Revenue | $24.6B | $23.9B | $26.6B | Declining |
| Net Income | $3.6B | $3.9B | $7.2B | Declining |
| Free Cash Flow | $5.3B | $5.3B | $7.4B | Declining |
| Gross Margin | 59.1% | 59.5% | 60.8% | Stable |
Recent events that affect our DHR analysis
DHR earnings report scheduled
Upcoming report. Consensus EPS estimate: $1.87. Revenue estimate: $6.13B. Our current Fair Value: $190.00 — a significant beat or miss could shift this estimate.
DHR analyst consensus: 92% bullish (22 of 24 analysts)
4 Strong Buy, 18 Buy, 2 Hold, 0 Sell, 0 Strong Sell. Consensus target: $256.05 (39.1% upside). Compare with our independent Fair Value: $190.00.
DHR beat EPS estimates by 6.5%
Reported EPS: $2.06 vs estimate $1.94. Earnings strength supports our Fair Value of $190.00 (3.2% above current price).
DHR filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
DHR filed quarterly report (10-Q)
Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →
DHR filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
DHR paid $0.4000/share dividend
Dividend Safety Grade: A. Payout ratio: 26.4%.
DHR filed annual report (10-K)
Annual filing with full-year financials. Our Altman Z-Score, Moat, and Fair Value models are derived from this data. View on SEC EDGAR →
DHR filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
DHR filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
DHR beat EPS estimates by 2.0%
Reported EPS: $2.23 vs estimate $2.19. Earnings strength supports our Fair Value of $190.00 (3.2% above current price).
DHR filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
DHR filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
DHR paid $0.3200/share dividend
Dividend Safety Grade: A. Payout ratio: 26.4%.
DHR filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
DHR beat EPS estimates by 9.8%
Reported EPS: $1.89 vs estimate $1.72. Earnings strength supports our Fair Value of $190.00 (3.2% above current price).
DHR filed quarterly report (10-Q)
Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →
DHR filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
DHR paid $0.3200/share dividend
Dividend Safety Grade: A. Payout ratio: 26.4%.
DHR filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
DHR filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
DHR filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
DHR beat EPS estimates by 9.5%
Reported EPS: $1.80 vs estimate $1.64. Earnings strength supports our Fair Value of $190.00 (3.2% above current price).
DHR filed quarterly report (10-Q)
Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →
DHR filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
DHR paid $0.3200/share dividend
Dividend Safety Grade: A. Payout ratio: 26.4%.
DHR filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
DHR beat EPS estimates by 14.4%
Reported EPS: $1.88 vs estimate $1.64. Earnings strength supports our Fair Value of $190.00 (3.2% above current price).
DHR filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
DHR filed quarterly report (10-Q)
Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →
DHR paid $0.3200/share dividend
Dividend Safety Grade: A. Payout ratio: 26.4%.
DHR filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
DHR filed annual report (10-K)
Annual filing with full-year financials. Our Altman Z-Score, Moat, and Fair Value models are derived from this data. View on SEC EDGAR →
DHR missed EPS estimates by 1.1%
Reported EPS: $2.14 vs estimate $2.16. Our Fair Value of $190.00 may face downward pressure if the trend continues.
DHR filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
DHR filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
Common questions about Danaher Corporation
What is Danaher Corporation stock price today?
Danaher Corporation (DHR) stock price is $184.04 as of the latest market close, traded on the NYSE exchange.
What does Danaher Corporation do?
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions.
What is Danaher Corporation market cap?
Danaher Corporation has a market capitalization of $130.26B, classifying it as a large-cap stock in the Healthcare sector.
What sector and industry is DHR in?
Danaher Corporation operates in the Healthcare sector, specifically within the Diagnostics & Research industry. It trades on the NYSE under the ticker symbol DHR.
Is DHR stock overvalued or undervalued?
Based on our valuation model, Danaher Corporation trades 3.1% below our fair value estimate — potentially undervalued.
- FairValueLabs Fair Value: $190.00
- Current Price: $184.04
- Valuation Zone: Watch Zone
What is DHR stock forecast and analyst target price?
Based on 22 Wall Street analysts, the consensus price target for Danaher Corporation is $256.05, implying upside of 39.1% from the current price.
- Analyst High Target: $310.00
- Analyst Low Target: $205.00
Note: Analyst targets are shown for reference and are not used in our valuation model.
Is Danaher Corporation revenue and earnings growing?
Here are the analyst consensus growth estimates for Danaher Corporation:
- Revenue growth (current year est.): 4.2%
- EPS growth (current year est.): 7.9%
- Revenue growth (next year est.): 5.7%
- EPS growth (next year est.): 8.0%
What are Danaher Corporation's key financial metrics?
| Metric | Latest | Trend |
|---|---|---|
| Revenue | $24.6B | Declining |
| Net Income | $3.6B | Declining |
| Free Cash Flow | $5.3B | Declining |
| Gross Margin | 59.1% | Stable |
What is DHR's P/E ratio?
The price-to-earnings ratio measures how much investors pay per dollar of earnings:
- Trailing P/E (last 12 months): 35.7x
- Forward P/E (next 12 months est.): 20.2x
- FairValueLabs Fair P/E: 30.4x
How volatile is DHR stock?
Danaher Corporation has a beta of 0.99, meaning it is roughly in line with overall market volatility. A beta above 1.0 indicates higher price swings relative to the S&P 500, while below 1.0 suggests more stability.
How much cash and debt does Danaher Corporation have?
Danaher Corporation's balance sheet shows:
- Total Cash: $5.70B
- Total Debt: $19.68B
- Net Cash Position: $-13.98B
A positive net cash position means the company holds more cash than debt, reducing financial risk.
What is Danaher Corporation's free cash flow?
Danaher Corporation generated $4.57B in trailing twelve-month free cash flow (from $6.44B in operating cash flow). Free cash flow represents the cash available for dividends, buybacks, and debt reduction after all capital expenditures.
Does Danaher Corporation pay a dividend, and is it safe?
Yes, Danaher Corporation pays a regular dividend. Here are the key metrics:
- Dividend Yield: 0.7%
- Payout Ratio: 26.4%
- Consecutive Years Paid: 34
- 5-Year Dividend Growth: -11.7%
- FairValueLabs Safety Grade: A
Is Danaher Corporation at risk of going bankrupt?
Danaher Corporation's Altman Z-Score is 3.87, placing it in the safe zone (above 3.0) — bankruptcy risk is low. The Z-Score uses five balance sheet ratios to predict bankruptcy probability within two years.
Does Danaher Corporation have a durable competitive advantage?
Danaher Corporation scores 2.6/5 stars (Narrow moat · eroding) in our moat analysis:
- ROIC Stability: 2/5
- Gross Margin Trend: 3/5
- Switching Costs: 3/5
A score above 3.5 suggests meaningful pricing power and a defensible market position.
What is DHR's return on equity (ROE)?
Danaher Corporation's return on equity is 7.1%. ROE measures how efficiently a company generates profits from shareholder equity. An ROE above 15% is generally considered strong, while below 10% may signal inefficiency.
How do I buy DHR stock?
DHR shares can be purchased through any brokerage account that provides access to the NYSE. Common steps:
- Open an account with a broker (e.g., Fidelity, Schwab, Interactive Brokers)
- Search for ticker symbol DHR
- Place a market or limit order for your desired number of shares
This is not investment advice. Always do your own research before buying any stock.
Is DHR a value stock or speculative?
FairValueLabs classifies Danaher Corporation as Value Investment. It exhibits consistent profitability, reasonable valuation, and financial stability — characteristics of a traditional value investment.
Who is the CEO of Danaher Corporation?
The current CEO of Danaher Corporation is Mr. Rainer M. Blair.
What is DHR's earnings per share (EPS)?
Earnings per share measures the company's profit allocated to each outstanding share:
- Trailing EPS (last 12 months): $5.15
- Forward EPS (next 12 months est.): $9.12
- Analyst consensus EPS (this year): $8.42
- Analyst consensus EPS (next year): $9.09
Other Healthcare companies analyzed by FairValueLabs
FairValueLabs Disclaimer
All valuations, scores, ratings, and classifications on this page are produced by the FairValueLabs internal valuation system. They do not represent actual market value, guaranteed outcomes, or professional investment advice. These are analytical estimates for educational and research purposes only.
This is not financial advice. All data is sourced from SEC EDGAR public filings. Always consult a qualified financial advisor before making investment decisions.
Last updated: Apr 22, 2026. Data sources: SEC EDGAR (financial statements), Yahoo Finance (market data, analyst consensus). Data may not reflect the most recent quarter.
DHR analysis methodology: How we calculate fair value, Z-Scores, and moat ratings